BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2725 related articles for article (PubMed ID: 1672344)

  • 41. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for quantitative and qualitative differences in functional activation of Mls-reactive T cell clones and hybridomas by antigen or TcR/CD3 antibodies.
    Gaugler B; Langlet C; Martin JM; Schmitt-Verhulst AM; Guimezanes A
    Eur J Immunol; 1991 Oct; 21(10):2581-9. PubMed ID: 1680703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neonatal tolerance induction in the thymus to MHC-class II-associated antigens. IV. Significance of intrathymic chimerism of blood-born Ia+ cells in Mls tolerance.
    Hosono M; Kurozumi M; Inaba M; Ideyama S; Tomana M; Gyotoku J; Katsura Y; Hosokawa T
    Cell Immunol; 1991 Sep; 136(2):373-87. PubMed ID: 1831406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic analysis of the presentation of minor lymphocyte-stimulating determinants. II. Differing non-MHC control of super-stimulatory and more poorly stimulatory Mls phenotypes.
    Ryan JJ; LeJeune HB; Mond JJ; Finkelman FD
    J Immunol; 1990 Apr; 144(7):2506-17. PubMed ID: 2138649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
    Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
    J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential susceptibility of cytotoxic and helper T cell precursors to neonatal tolerization to histocompatibility antigens.
    Ishizaka ST; Carnaud C; Stutman O
    J Immunol; 1986 Oct; 137(7):2093-9. PubMed ID: 2944947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of streptococcal antigen-specific CD8+, MHC class I-restricted, T cell clones that down-regulate in vitro antibody synthesis.
    Walker PR; Fellowes R; Hecht EM; Lehner T
    J Immunol; 1991 Nov; 147(10):3370-80. PubMed ID: 1834737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism of the induction of autoimmune disease by graft-versus-host reaction. Role of CD8+ cells in the development of hepatic and ductal lesions induced by CD4+ cells in MHC class I plus II-different host.
    Suzuki K; Narita T; Yui R; Asakura H; Fujiwara M
    Lab Invest; 1994 May; 70(5):609-19. PubMed ID: 8196358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymphocyte-mediated activation of cultured endothelial cells (EC). CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing EC class I MHC and intercellular adhesion molecule-1 expression.
    Doukas J; Pober JS
    J Immunol; 1990 Aug; 145(4):1088-98. PubMed ID: 1974272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polyclonal B cell activation by B cell differentiation factor B151-TRF2. I. Involvement of self-Ia recognition process mediated by B cells.
    Ono S; Takahama Y; Hamaoka T
    J Immunol; 1986 Aug; 137(4):1149-56. PubMed ID: 3090140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules.
    Majlessi L; Bordenave G
    Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoimmunity after induction of neonatal tolerance to alloantigens: role of B cell chimerism and F1 donor B cell activation.
    Luzuy S; Merino J; Engers H; Izui S; Lambert PH
    J Immunol; 1986 Jun; 136(12):4420-6. PubMed ID: 2940295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoimmunity, hyporeactivity to T cell mitogens and lymphoproliferative disorders following neonatal induction of transplantation tolerance in mice.
    Jánossy T; Baranyi L; Knulst AC; Vizler C; Benner R; Kelényi G; Végh P
    Eur J Immunol; 1993 Nov; 23(11):3011-20. PubMed ID: 8223878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand.
    Bishop GA; Warren WD; Berton MT
    Eur J Immunol; 1995 May; 25(5):1230-8. PubMed ID: 7539751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neonatal tolerance induction in the thymus to MHC-class II-associated antigens. I. Preferential induction of tolerance to Mls antigens and resistance to allo-MHC antigens.
    Hosono M; Kina T; Hosokawa T; Katsura Y
    Cell Immunol; 1986 Nov; 103(1):1-10. PubMed ID: 3542233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4.
    Eichmann K; Jönsson JI; Falk I; Emmrich F
    Eur J Immunol; 1987 May; 17(5):643-50. PubMed ID: 3108015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neonatal induction of allogeneic tolerance prevents T cell-mediated autoimmunity in NOD mice.
    Bendelac A; Boitard C; Bach JF; Carnaud C
    Eur J Immunol; 1989 Apr; 19(4):611-6. PubMed ID: 2525099
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T cell receptor targeting to thymic cortical epithelial cells in vivo induces survival, activation and differentiation of immature thymocytes.
    Müller KP; Kyewski BA
    Eur J Immunol; 1993 Jul; 23(7):1661-70. PubMed ID: 8100778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Masking of veto function in vivo by activated CD4+ T lymphocytes.
    Rammensee HG; Hügin D
    Eur J Immunol; 1989 Apr; 19(4):643-8. PubMed ID: 2567242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 137.